http://www.tkuhn.ch/bel2nanopub/RAbNKgzey8-OQHOM8qOyTFFk6kHw0lM5ZS1Myu075557o#Head http://www.tkuhn.ch/bel2nanopub/RAbNKgzey8-OQHOM8qOyTFFk6kHw0lM5ZS1Myu075557o http://www.nanopub.org/nschema#hasAssertion http://www.tkuhn.ch/bel2nanopub/RAbNKgzey8-OQHOM8qOyTFFk6kHw0lM5ZS1Myu075557o#assertion http://www.tkuhn.ch/bel2nanopub/RAbNKgzey8-OQHOM8qOyTFFk6kHw0lM5ZS1Myu075557o http://www.nanopub.org/nschema#hasProvenance http://www.tkuhn.ch/bel2nanopub/RAbNKgzey8-OQHOM8qOyTFFk6kHw0lM5ZS1Myu075557o#provenance http://www.tkuhn.ch/bel2nanopub/RAbNKgzey8-OQHOM8qOyTFFk6kHw0lM5ZS1Myu075557o http://www.nanopub.org/nschema#hasPublicationInfo http://www.tkuhn.ch/bel2nanopub/RAbNKgzey8-OQHOM8qOyTFFk6kHw0lM5ZS1Myu075557o#pubinfo http://www.tkuhn.ch/bel2nanopub/RAbNKgzey8-OQHOM8qOyTFFk6kHw0lM5ZS1Myu075557o http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.nanopub.org/nschema#Nanopublication http://www.tkuhn.ch/bel2nanopub/RAbNKgzey8-OQHOM8qOyTFFk6kHw0lM5ZS1Myu075557o#assertion http://www.tkuhn.ch/bel2nanopub/RAbNKgzey8-OQHOM8qOyTFFk6kHw0lM5ZS1Myu075557o#_1 http://semanticscience.org/resource/SIO_000139 http://www.tkuhn.ch/bel2nanopub/RAbNKgzey8-OQHOM8qOyTFFk6kHw0lM5ZS1Myu075557o#_2 http://www.tkuhn.ch/bel2nanopub/RAbNKgzey8-OQHOM8qOyTFFk6kHw0lM5ZS1Myu075557o#_1 http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://amigo.geneontology.org/amigo/term/GO:0042789 http://www.tkuhn.ch/bel2nanopub/RAbNKgzey8-OQHOM8qOyTFFk6kHw0lM5ZS1Myu075557o#_2 http://purl.obolibrary.org/obo/RO_0002204 http://www.genenames.org/cgi-bin/gene_symbol_report?hgnc_id=6349 http://www.tkuhn.ch/bel2nanopub/RAbNKgzey8-OQHOM8qOyTFFk6kHw0lM5ZS1Myu075557o#_2 http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI_36080 http://www.tkuhn.ch/bel2nanopub/RAbNKgzey8-OQHOM8qOyTFFk6kHw0lM5ZS1Myu075557o#_3 http://semanticscience.org/resource/SIO_000139 http://www.tkuhn.ch/bel2nanopub/RAbNKgzey8-OQHOM8qOyTFFk6kHw0lM5ZS1Myu075557o#_4 http://www.tkuhn.ch/bel2nanopub/RAbNKgzey8-OQHOM8qOyTFFk6kHw0lM5ZS1Myu075557o#_3 http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://amigo.geneontology.org/amigo/term/GO:0042789 http://www.tkuhn.ch/bel2nanopub/RAbNKgzey8-OQHOM8qOyTFFk6kHw0lM5ZS1Myu075557o#_4 http://purl.obolibrary.org/obo/RO_0002204 http://www.genenames.org/cgi-bin/gene_symbol_report?hgnc_id=6348 http://www.tkuhn.ch/bel2nanopub/RAbNKgzey8-OQHOM8qOyTFFk6kHw0lM5ZS1Myu075557o#_4 http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI_36080 http://www.tkuhn.ch/bel2nanopub/RAbNKgzey8-OQHOM8qOyTFFk6kHw0lM5ZS1Myu075557o#_5 http://purl.obolibrary.org/obo/BFO_0000066 http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?id=9606 http://www.tkuhn.ch/bel2nanopub/RAbNKgzey8-OQHOM8qOyTFFk6kHw0lM5ZS1Myu075557o#_5 http://www.w3.org/1999/02/22-rdf-syntax-ns#object http://www.tkuhn.ch/bel2nanopub/RAbNKgzey8-OQHOM8qOyTFFk6kHw0lM5ZS1Myu075557o#_3 http://www.tkuhn.ch/bel2nanopub/RAbNKgzey8-OQHOM8qOyTFFk6kHw0lM5ZS1Myu075557o#_5 http://www.w3.org/1999/02/22-rdf-syntax-ns#predicate http://www.selventa.com/vocabulary/decreases http://www.tkuhn.ch/bel2nanopub/RAbNKgzey8-OQHOM8qOyTFFk6kHw0lM5ZS1Myu075557o#_5 http://www.w3.org/1999/02/22-rdf-syntax-ns#subject http://www.tkuhn.ch/bel2nanopub/RAbNKgzey8-OQHOM8qOyTFFk6kHw0lM5ZS1Myu075557o#_1 http://www.tkuhn.ch/bel2nanopub/RAbNKgzey8-OQHOM8qOyTFFk6kHw0lM5ZS1Myu075557o#_5 http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.w3.org/1999/02/22-rdf-syntax-ns#Statement http://www.tkuhn.ch/bel2nanopub/RAbNKgzey8-OQHOM8qOyTFFk6kHw0lM5ZS1Myu075557o#assertion http://www.w3.org/2000/01/rdf-schema#label tscript(p(HGNC:KLF5)) -| tscript(p(HGNC:KLF4)) http://www.tkuhn.ch/bel2nanopub/RAbNKgzey8-OQHOM8qOyTFFk6kHw0lM5ZS1Myu075557o#provenance http://resource.belframework.org/belframework/1.0/knowledge/large_corpus.bel http://purl.org/dc/elements/1.1/description Approximately 61,000 statements. http://resource.belframework.org/belframework/1.0/knowledge/large_corpus.bel http://purl.org/dc/elements/1.1/rights Copyright (c) 2011-2012, Selventa. All rights reserved. http://resource.belframework.org/belframework/1.0/knowledge/large_corpus.bel http://purl.org/dc/elements/1.1/title BEL Framework Large Corpus Document http://resource.belframework.org/belframework/1.0/knowledge/large_corpus.bel http://purl.org/pav/authoredBy http://www.tkuhn.ch/bel2nanopub/RAbNKgzey8-OQHOM8qOyTFFk6kHw0lM5ZS1Myu075557o#_8 http://resource.belframework.org/belframework/1.0/knowledge/large_corpus.bel http://purl.org/pav/version 1.4 http://www.tkuhn.ch/bel2nanopub/RAbNKgzey8-OQHOM8qOyTFFk6kHw0lM5ZS1Myu075557o#_6 http://purl.org/dc/elements/1.1/identifier Cellular and Molecular Biology 26: Transcription Factor Function Abstract 1692 http://www.tkuhn.ch/bel2nanopub/RAbNKgzey8-OQHOM8qOyTFFk6kHw0lM5ZS1Myu075557o#_6 http://purl.org/dc/elements/1.1/title Cellular and Molecular Biology 26: Transcription Factor Function Abstract 1692 http://www.tkuhn.ch/bel2nanopub/RAbNKgzey8-OQHOM8qOyTFFk6kHw0lM5ZS1Myu075557o#_6 http://purl.org/dc/elements/1.1/type Other http://www.tkuhn.ch/bel2nanopub/RAbNKgzey8-OQHOM8qOyTFFk6kHw0lM5ZS1Myu075557o#_7 http://www.w3.org/ns/prov#value A group of 2-indolyl imidazol [4,5-d] phenanthroline derivatives with potent and selective anti-proliferative activity against several types of human cancer has been developed. A pattern of particular tumor-type selectivity was shown in the in vitro anti-tumor screening of the National Cancer Institute (NCI) Developmental Therapeutics Program. Lead compounds showed potent and selective growth inhibition of colon cancer [N= 6 cell lines; GI50 0.53 +- 0.11 (uM)], leukemia [N=3 cell lines; GI50 0.17 +- 0.09 (uM)], non-small cell lung cancer [NSCLC N = 8 cell lines; GI50 0.95 +- 0.4 (uM)], and prostate cancer [N= 2 cell lines; GI50 0.22 +- 0.05 (uM)]. These compounds also exhibited in vivo activity in the Hollow Fiber Assay, and in xenograft models of human colon carcinoma (HT-29) and NSCLC (H460) in athymic \"nude\" mice. These studies demonstrated significant tumor growth inhibition and in vivo cytocidal effect on implanted cancer cells. Dose-schedule studies defined oral and intraperitoneal therapeutic dosages ranging from 40 mg/Kg to 100 mg/Kg daily x 5 days (tumor volume change ratio T/C = 15-45 %) with no signs of apparent toxicity. Analysis of gene expression by quantitative RT-PCR in tumor xenograft tissue from treated mice showed strong induction of the tumor suppressor gene Kruppel -like factor 4 (KLF4) and decreased expression of the cell cycle associated gene Cyclin D1. Cell cycle analysis by flow cytometry showed that these compounds block the cell cycle progression of HT-29 cells at G1 phase. Additional mechanism of action studies demonstrated that they reduce the concentration of available intracellular zinc, reflected by decreased fluorescent count using the zinc-sensitive dye zinquin, and decreased gene expression of the zinc-storage protein metallothionein 1A. Further studies showed that this effect translated into a series of events that included: (1) reduced gene expression of the metal-responsive transcription factor 1 (MTF-1), as determined by RT-PCR; (2) down-regulation of the KLF4- transcriptional antagonist Kruppel-like factor 5 (KLF5) and induction of KLF4, as determined by RT-PCR and Western blot; and (3) altered expression of several known KLF-4-regulated genes involved in cell cycle progression, including cyclin D1. Taken together, the results indicate intracellular zinc depletion leading to induction of KLF4 as a key process involved in the mechanism of anti-tumor activity of these novel compounds. Additional mechanism of action studies demonstrated that they reduce the concentration of available intracellular zinc, reflected by decreased fluorescent count using the zinc-sensitive dye zinquin, and decreased gene expression of the zinc-storage protein metallothionein 1A. Further studies showed that this effect translated into a series of events that included: (1) reduced gene expression of the metal-responsive transcription factor 1 (MTF-1), as determined by RT-PCR; (2) down-regulation of the KLF4- transcriptional antagonist Kruppel-like factor 5 (KLF5) and induction of KLF4, as determined by RT-PCR and Western blot; and (3) altered expression of several known KLF-4-regulated genes involved in cell cycle progression, including cyclin D1. http://www.tkuhn.ch/bel2nanopub/RAbNKgzey8-OQHOM8qOyTFFk6kHw0lM5ZS1Myu075557o#_7 http://www.w3.org/ns/prov#wasQuotedFrom http://www.tkuhn.ch/bel2nanopub/RAbNKgzey8-OQHOM8qOyTFFk6kHw0lM5ZS1Myu075557o#_6 http://www.tkuhn.ch/bel2nanopub/RAbNKgzey8-OQHOM8qOyTFFk6kHw0lM5ZS1Myu075557o#_8 http://www.w3.org/2000/01/rdf-schema#label Selventa http://www.tkuhn.ch/bel2nanopub/RAbNKgzey8-OQHOM8qOyTFFk6kHw0lM5ZS1Myu075557o#assertion http://www.w3.org/ns/prov#hadPrimarySource http://www.tkuhn.ch/bel2nanopub/RAbNKgzey8-OQHOM8qOyTFFk6kHw0lM5ZS1Myu075557o#_6 http://www.tkuhn.ch/bel2nanopub/RAbNKgzey8-OQHOM8qOyTFFk6kHw0lM5ZS1Myu075557o#assertion http://www.w3.org/ns/prov#wasDerivedFrom http://resource.belframework.org/belframework/1.0/knowledge/large_corpus.bel http://www.tkuhn.ch/bel2nanopub/RAbNKgzey8-OQHOM8qOyTFFk6kHw0lM5ZS1Myu075557o#assertion http://www.w3.org/ns/prov#wasDerivedFrom http://www.tkuhn.ch/bel2nanopub/RAbNKgzey8-OQHOM8qOyTFFk6kHw0lM5ZS1Myu075557o#_7 http://www.tkuhn.ch/bel2nanopub/RAbNKgzey8-OQHOM8qOyTFFk6kHw0lM5ZS1Myu075557o#pubinfo http://www.tkuhn.ch/bel2nanopub/RAbNKgzey8-OQHOM8qOyTFFk6kHw0lM5ZS1Myu075557o http://purl.org/dc/terms/created 2014-07-03T14:29:43.303+02:00 http://www.tkuhn.ch/bel2nanopub/RAbNKgzey8-OQHOM8qOyTFFk6kHw0lM5ZS1Myu075557o http://purl.org/pav/createdBy http://orcid.org/0000-0001-6818-334X http://www.tkuhn.ch/bel2nanopub/RAbNKgzey8-OQHOM8qOyTFFk6kHw0lM5ZS1Myu075557o http://purl.org/pav/createdBy http://orcid.org/0000-0002-1267-0234